Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NATIONAL DME COMPETITIVE BIDDING AMONG MEDICARE ANTI-FRAUD PROPOSALS FROM ADMINISTRATION; SENATE FINANCE MEMBERS SEEKING LOWER SURETY BOND THRESHOLD

This article was originally published in The Gray Sheet

Executive Summary

The White House is proposing to expand Medicare competitive bidding programs for durable medical equipment beyond their current demonstration status and implement them nationally. Under one of 10 Medicare waste, fraud and abuse legislative initiatives unveiled by President Clinton Jan. 24 during his weekly radio address, the Health Care Financing Administration would "do what most private and other government health care purchasers do to control cost -- lower costs by injecting competition into the pricing for equipment and non-physician services."

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009517

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel